---
schema_version: "secwatch.filing_event.v1"
accession: "0001759655-22-000041"
form_type: "8-K"
ticker: "PRVA"
cik: "0001759655"
company_name: "Privia Health Group, Inc."
filed_at: "2022-03-31T23:59:59+00:00"
generated_at: "2026-06-26T12:23:12.286619+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Privia Health appoints Nancy Cocozza to Board of Directors, effective April 1, 2022

## Summary
- Board expanded from 9 to 10; Nancy Cocozza elected director effective April 1, 2022.
- Cocozza appointed to Audit Committee, replacing Will Sherrill.
- She is a former Aetna senior VP and Medicare business leader with 30+ years in payer market.
- Initial restricted stock unit award of $175,000 in common stock.
- Enters standard indemnification agreement with Company.

## SEC filing metadata
- accession: 0001759655-22-000041
- form_type: 8-K
- ticker: PRVA
- cik: 0001759655
- company_name: Privia Health Group, Inc.
- filed_at: 2022-03-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759655/000175965522000041/0001759655-22-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759655/000175965522000041/prva-20220330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001759655-22-000041
- JSON: https://secwatch.observer/filing/0001759655-22-000041.json
- Plain text: https://secwatch.observer/filing/0001759655-22-000041.txt

## Key facts
- Executive change
  Nancy Cocozza was elected as Director at Privia Health Group, Inc..
  - Action: elected
  - Role: Director
  source text: elected Nancy Cocozza to fill the newly created vacancy on the Board, effective April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000175965522000041/0001759655-22-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.